Latest News
PatientView’s Corporate Reputation of Pharma 2023/24: Insights from Specialised Cancer Patient Groups
July 2024: The field of oncology, cancer research and cancer treatment has seen continued investment over the last few years. In the UK, cancer incidence rates are projected to rise… Continue reading “PatientView’s Corporate Reputation of Pharma 2023/24: Insights from Specialised Cancer Patient Groups”